on 24 Sep 2024
Last Applicant/ Owned by
88212 Ravensburg
DE
Serial Number
79379105 filed on 21st Feb 2023
Registration Number
7510448 registered on 24th Sep 2024
Correspondent Address
M. Scott Alprin
Filing Basis
1. filing basis filed as 66 a
Disclaimer
NO DATA
Pharmaceutical drug development services, namely, development of syringes and instruments for injections, injectors and packaging for the aforesaid goods, for others; chemical, physical and process engineering tests, in particular laboratory tests, namely, engineering material testing, engineering product testing, engineering quality testing for manufacturing processes; development and conducting Read More
Pharmaceutical drug development services, namely, development of syringes and instruments for injections, injectors and packaging for the aforesaid goods, for others; chemical, physical and process engineering tests, in particular laboratory tests, namely, engineering material testing, engineering product testing, engineering quality testing for manufacturing processes; development and conducting of pharmacological and microbiological tests and processes, including for others, namely, testing of pharmaceuticals and pharmaceutical drug development services
N/A
N/A
Bottling of liquid and solid substances, in particular of pharmaceuticals, medicines and solutions, for others
N/A
N/A
Empty medical injection apparatus, namely, syringes for injections, injectors, auto-injectors and single-chamber and dual-chamber disposable syringes; medicine instruments in the form of containers for administering medicines, namely, medical vials, syringes, medical cartridges and medical dual-chamber vials and syringes of glass or plastic; holders specially adapted for syringes
N/A
N/A
Pharmaceutical preparations and medicines for the prevention of infections, cancer, depression, heart disease, vascular disease, intestinal disorder, lung and bronchial disfunction, liver disfunction, oral and laryngeal disease, optical and cranial disorders; solutions to be taken orally, sterile solutions and injection solutions for medical purpose for treatment of infections, cancer, depression, heart disease, vascular disease, intestinal disorder, lung and bronchial disfunction, liver disfunction, oral and laryngeal disease, optical and cranial disorders; eyedrops, contact lens solutions; swabs for medical purposes; plasters, materials for dressings, namely, medical plasters; filled medical injection systems, for treatment of infections, cancer, depression, heart disease, vascular disease, intestinal disorder, lung and bronchial disfunction, liver disfunction, oral and laryngeal disease, optical and cranial disorders in particular syringes and instruments for injections, injectors, auto-injectors and single-chamber and dual-chamber disposable syringes; packaging units packaged individually or in combination with one another for medical and medical technology purposes, namely, packaging units containing prefilled prepared syringes, disposable syringes, disposable cannulae, ampoules and medicine vials for treatment of infections, cancer, depression, heart disease, vascular disease, intestinal disorder, lung and bronchial disfunction, liver disfunction, oral and laryngeal disease, optical and cranial disorders
N/A
N/A
No 79379105
No Service Mark
No 0013048C1
No
No
No
No
Yes
Yes
No
No
26.01.21 -
Circles that are totally or partially shaded
26.17.01 -
Straight line(s), band(s) or bar(s)
26.17.05 -
Horizontal line(s), band(s) or bar(s)
Status Date | Action Taken |
---|---|
24th Sep 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
24th Sep 2024 | REGISTERED-PRINCIPAL REGISTER |
09th Jul 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
09th Jul 2024 | PUBLISHED FOR OPPOSITION |
19th Jun 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
31st May 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
30th May 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
30th May 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
30th May 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
19th Dec 2023 | REFUSAL PROCESSED BY IB |